Loading...
Immunotherapy failure in adrenocortical cancer: where next?
Immunotherapy is widely used in the treatment of different cancer types, including metastatic melanoma, non-small cell lung cancer, renal cell carcinoma and urothelial cancer. The results of the phase I JAVELIN study failed to demonstrate a substantial activity of the PDL-1 inhibitor Avelumab in adv...
Saved in:
Published in: | Endocr Connect |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Bioscientifica Ltd
2018
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280582/ https://ncbi.nlm.nih.gov/pubmed/30400026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0398 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|